0001104659-21-054978.txt : 20210426 0001104659-21-054978.hdr.sgml : 20210426 20210426170911 ACCESSION NUMBER: 0001104659-21-054978 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210422 FILED AS OF DATE: 20210426 DATE AS OF CHANGE: 20210426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xu Yuan CENTRAL INDEX KEY: 0001858214 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 21854882 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm2114204-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-04-22 0 0001744659 Akero Therapeutics, Inc. AKRO 0001858214 Xu Yuan C/O AKERO THERAPEUTICS, INC., 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 28.79 2021-04-22 4 A 0 26000 0 D 2031-04-22 Common Stock 26000 26000 D This option shall vest and become exercisable in 36 equal monthly installments, commencing on April 22, 2021. /s/ Jonathan Young, attorney-in-fact 2021-04-26